IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Fate Therapeutics
Merck Sharp & Dohme LLC
Oncology Institute of Southern Switzerland
Roswell Park Cancer Institute
Rutgers, The State University of New Jersey